Testing the Addition of Pedmark to Cisplatin Chemotherapy for Reducing Drug-Induced Ear Damage in Men With Stage II-III Metastatic Testicular Germ Cell Tumors

Clinical trial NCT07218913 · RECRUITING

Trial details

NCT number: NCT07218913
Sponsor: City of Hope Medical Center
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Hearing Loss Metastatic Malignant Germ Cell Tumor Metastatic Malignant Nongerminomatous Germ Cell Tumor Metastatic Malignant Testicular Non-Seminomatous Germ Cell Tumor Metastatic Testicular Seminoma Stage II Testicular Cancer AJCC v8 Stage III Testicular Cancer AJCC v8

Start date: 2026-02-19
Primary completion: 2031-01-22
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.